Cytarabine Hydrochloride for Injection Analysis Service

Cytarabine Hydrochloride for Injection Analysis Service

Precision and Accuracy for Cytarabine Hydrochloride Analysis

Cytarabine hydrochloride for injection is a sterile lyophilized product of cytarabine hydrochloride. Cytarabine hydrochloride is a cytotoxic agent used for hematological malignancies and lymphomas. CD BioGlyco provides reliable cytarabine hydrochloride for injection analysis service. Our mature experience and expertise in Pharmaceutical Analysis enable us to deliver high-quality solutions to our clients. Moreover, we provide professional Biological Evaluation and Pharmaceutical Excipient Analysis services.

  • Rapid identification service
    Our lab provides rapid and simple identification services:
    • Ultraviolet-visible spectrophotometer
    • Infrared absorption spectroscopy
    • Chloride identification
    • Acidity test
    • Clarity test
    • Moisture test
  • Cytarabine hydrochloride and related substance determination
    • We provide a high-sensitive substance determination service through thin-layer chromatography (TLC), non-aqueous titration, and high-performance liquid chromatography (HPLC). Moreover, we test the limit of quantification, minimum detection, and peak purity for HPLC analysis.
    • Based on the effect of electrolytic current on the intensity of chemiluminescence, our researchers measure the concentration by controlling the current level. We provide trace, high-speed, and automated flow injection chemiluminescence analysis to our clients.
  • Bacterial endotoxin test
    We utilize Tachypiens amebocyte lysate (TAL) or Limulus amebocyte lysate (LAL) to detect bacterial endotoxins produced by gram-negative bacteria to determine if the bacterial endotoxins in cytarabine hydrochloride for injection comply with standards. We usually use the gel-clot, turbidimetric, and chromogenic.
  • Abnormal toxicity determination
    At CD BioGlyco, mouse and guinea pig model groups are established and administered the drug intravenously. The animals are observed for abnormal reactions or deaths within a specified period and are examined for contaminating exogenous toxic substances and other unsafe factors.

Fig.1 Schematic diagram of cytarabine hydrochloride for injection service. (CD BioGlyco)Fig.1 Schematic diagram of cytarabine hydrochloride for injection service. (CD BioGlyco)

Publication Data

Technology: Scanning electron microscopy, Spectrophotometer, HPLC

Journal: Journal of Biomedical Nanotechnology

Published: 2007

IF: 2.9

Results: In this work, researchers synthesized and characterized cytarabine hydrochloride nanoparticles. The in vitro drug release results showed that cytarabine hydrochloride nanoparticles effectively prolonged the lifespan of mice. Pharmacokinetic studies on the mouse model revealed that cytarabine hydrochloride was still detectable after 24 h. Therefore, the cytarabine hydrochloride nanoparticles delivery system has a significant effect in the treatment of lymphoma.

Fig.2 In vitro release profiles of free cytarabine hydrochloride and cytarabine hydrochloride nanoparticles. (Ruckmani, et al., 2007)Fig.2 In vitro release profiles of free cytarabine hydrochloride and cytarabine hydrochloride nanoparticles. (Ruckmani, et al., 2007)

Advantages of Us

  • Our research team optimizes the mobile phase according to the molecular characteristics of cytarabine hydrochloride to make the separation and retention time of cytarabine hydrochloride more reasonable.
  • The measurement service we provide determines both the cytarabine hydrochloride for injection content and related substances.
  • Our high-efficiency service quality and serious service attitude have been well received by our partners.

With a professional analytical team, CD BioGlyco provides Pharmaceutical and Biological analysis services. Our analytical services have helped many of our clients solve problems promptly and drive their projects forward. Please feel free to contact us if you are interested in cytarabine hydrochloride for injection analysis.


  1. Ruckmani, K.; et al. Nanoparticular drug delivery system of cytarabine hydrochloride (CTH) for improved treatment of lymphoma. Journal of Biomedical Nanotechnology. 2007, 3(1): 90-96.
This service is for Research Use Only, not intended for any clinical use.

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.